| P50 | author | Reinaldo M. Martins | Q37368460 |
| | Alexandre Ribeiro Fernandes | Q96037580 |
| P2093 | author name string | Akira Homma | |
| | Helena Keico Sato | |
| | Ana Luiza Braz Pavão | |
| | Maria da Luz Fernandes Leal | |
| | Maria de Lourdes S Maia | |
| | Patricia Mandali de Figueiredo | |
| | Patrícia Mouta Nunes de Oliveira | |
| | Paulo Roberto Gomes dos Santos | |
| | Renate Mohrdieck | |
| | Sandra Maria D Carvalho | |
| | Vanessa Dos Reis von Doellinger | |
| P2860 | cites work | Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data | Q31115845 |
| | Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31116047 |
| | The early use of yellow fever virus strain 17D for vaccine production in Brazil--a review. | Q34373395 |
| | Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events | Q34556876 |
| | Review of the risks and benefits of yellow fever vaccination including some new analyses | Q38006992 |
| | Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. | Q38080334 |
| | Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil | Q39595868 |
| | The phylogeny of yellow fever virus 17D vaccines | Q40301491 |
| | Short report: Incidence of yellow fever vaccine-associated neurotropic disease | Q40372050 |
| | Viscerotropic disease following yellow fever vaccination in Peru | Q40382408 |
| | Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. | Q40457193 |
| | Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. | Q40459658 |
| | Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial | Q40504574 |
| | Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial | Q40522982 |
| | Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys | Q40546858 |
| | Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. | Q40691602 |
| | THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS | Q41096290 |
| | Epidemiologic methods in immunization programs | Q41341515 |
| | Genetic variability among yellow fever virus 17D substrains | Q42989276 |
| | Yellow Fever Vaccine Post-marketing Surveillance in Brazil | Q56795568 |
| | The reporting sensitivities of two passive surveillance systems for vaccine adverse events | Q57307502 |
| | Clinical profile and outcome of children with opsoclonus-myoclonus syndrome | Q85896140 |
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | yellow fever | Q154874 |
| | yellow fever virus | Q836749 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 6676-6682 | |
| P577 | publication date | 2014-05-14 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil | |
| P478 | volume | 32 | |